Galantamine as benzofuro-benzazepine alkaloid used in cognition and dementia
Journal Title: World Journal of Pharmaceutical Sciences - Year 2017, Vol 5, Issue 4
Abstract
Galantamine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Galantamine is in a class of medications called acetyl cholinesterase inhibitors. It works by increasing the amount of a certain natural substance in the brain that is needed for memory and thought. Galantamine may improve the ability to think and remember or slow the loss of these abilities in people who have AD. However, galantamine will not cure AD or prevent the loss of mental abilities at some time in the future.
Authors and Affiliations
Dhrubo Jyoti Sen
Keywords
Related Articles
- EP ID EP328297
- DOI -
- Views 52
- Downloads 0
Optimization of Microwave Assisted Extraction of Total Phenolic Contents from Triticum aestivum L. Whole-grain Cereal
Whole-grain cereals have unique blend of bioactive constituents and antioxidants which are proposed to be responsible for the health profits of whole-grain consumption. Nevertheless, phytochemicals and antioxidants in wh...
Assessment of knowledge and roles of patent medicine vendors in the implementation of national malaria treatment policy in Nigeria
Introduction: Patent Medicine Vendors (PMVs) are the first source of care for both children and adults seeking malaria treatment. This study sought to investigate the knowledge and roles of the PMVs in the implementation...
Sufficient conditions in the collision avoidance problem under geometrical and integral limitations on control
The paper considers the collision avoidance problem in a system, described by a controlled equation in partial derivatives, containing the second derivative with respect to time and elliptic operator. New spaces, dependi...
Sedative properties of the drug "FLEGMEN" on the basis of clinical-pharmacological tests
Background. Distress, due to pain, fear/anxiety, dyspnea, or delirium is common among critically ill patients. Distress may manifest clinically as agitation that is often associated with ventilator asynchrony and vital s...
The development and validation studies of RP-HPLC method – A review
Today there are many different strategies stating High Performance Liquid Chromatographic Method Development as well as RP-HPLC Technique [8-9]. This review describes strategies for the systematic Development of High per...